305 related articles for article (PubMed ID: 31767436)
1. Cost-Utility Analysis of Glaucoma Medication Adherence.
Newman-Casey PA; Salman M; Lee PP; Gatwood JD
Ophthalmology; 2020 May; 127(5):589-598. PubMed ID: 31767436
[TBL] [Abstract][Full Text] [Related]
2. Comparative Cost-effectiveness of the Baerveldt Implant, Trabeculectomy With Mitomycin, and Medical Treatment.
Kaplan RI; De Moraes CG; Cioffi GA; Al-Aswad LA; Blumberg DM
JAMA Ophthalmol; 2015 May; 133(5):560-7. PubMed ID: 25741886
[TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
[TBL] [Abstract][Full Text] [Related]
4. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT.
Gazzard G; Konstantakopoulou E; Garway-Heath D; Garg A; Vickerstaff V; Hunter R; Ambler G; Bunce C; Wormald R; Nathwani N; Barton K; Rubin G; Morris S; Buszewicz M
Health Technol Assess; 2019 Jun; 23(31):1-102. PubMed ID: 31264958
[TBL] [Abstract][Full Text] [Related]
5. The cost-effectiveness of medication, laser trabeculoplasty, and trabeculectomy for treatment of open-angle glaucoma in South Korea.
Choi JA; Song LD; Choi S; Park SM; Kwon JW; Jee D
Medicine (Baltimore); 2019 Jan; 98(2):e14026. PubMed ID: 30633194
[TBL] [Abstract][Full Text] [Related]
6. Cost-Effectiveness Analysis of Minimally Invasive Trabecular Meshwork Stents with Phacoemulsification.
Sood S; Heilenbach N; Sanchez V; Glied S; Chen S; Al-Aswad LA
Ophthalmol Glaucoma; 2022; 5(3):284-296. PubMed ID: 34563713
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of medications compared with laser trabeculoplasty in patients with newly diagnosed open-angle glaucoma.
Stein JD; Kim DD; Peck WW; Giannetti SM; Hutton DW
Arch Ophthalmol; 2012 Apr; 130(4):497-505. PubMed ID: 22332202
[TBL] [Abstract][Full Text] [Related]
8. Maximizing cost-effectiveness by adjusting treatment strategy according to glaucoma severity.
Guedes RAP; Guedes VMP; Gomes CEM; Chaoubah A
Medicine (Baltimore); 2016 Dec; 95(52):e5745. PubMed ID: 28033286
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Advanced Glaucoma Study: a multicentre randomised controlled trial comparing primary medical treatment with primary trabeculectomy for people with newly diagnosed advanced glaucoma-study protocol.
King AJ; Fernie G; Azuara-Blanco A; Burr JM; Garway-Heath T; Sparrow JM; Vale L; Hudson J; MacLennan G; McDonald A; Barton K; Norrie J
Br J Ophthalmol; 2018 Jul; 102(7):922-928. PubMed ID: 29074496
[TBL] [Abstract][Full Text] [Related]
10. The Association between Medication Adherence and Visual Field Progression in the Collaborative Initial Glaucoma Treatment Study.
Newman-Casey PA; Niziol LM; Gillespie BW; Janz NK; Lichter PR; Musch DC
Ophthalmology; 2020 Apr; 127(4):477-483. PubMed ID: 31932093
[TBL] [Abstract][Full Text] [Related]
11. Comparative Cost-effectiveness of Trabeculectomy versus MicroShunt in the US Medicare System.
Atik A; Fahy ET; Rhodes LA; Samuels BC; Mennemeyer ST; Girkin CA
Ophthalmology; 2022 Oct; 129(10):1142-1151. PubMed ID: 35636620
[TBL] [Abstract][Full Text] [Related]
12. Cost-Utility Analysis of a Medication Adherence-Enhancing Educational Intervention for Glaucoma.
Hung A; Williams AM; Newman-Casey PA; Muir KW; Gatwood J
Ophthalmol Glaucoma; 2023; 6(4):395-404. PubMed ID: 36707031
[TBL] [Abstract][Full Text] [Related]
13. The Cost-Effectiveness of Bimodal Stimulation Compared to Unilateral and Bilateral Cochlear Implant Use in Adults with Bilateral Severe to Profound Deafness.
Theriou C; Fielden CA; Kitterick PT
Ear Hear; 2019; 40(6):1425-1436. PubMed ID: 30998548
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of treating normal tension glaucoma.
Li EY; Tham CC; Chi SC; Lam DS
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3394-9. PubMed ID: 23599342
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of standalone trabecular micro-bypass stents in patients with mild-to-moderate open-angle glaucoma in Canada.
Patel V; Ahmed I; Podbielski D; Falvey H; Murray J; Goeree R
J Med Econ; 2019 Apr; 22(4):390-401. PubMed ID: 30663456
[TBL] [Abstract][Full Text] [Related]
16. More frequent, more costly? Health economic modelling aspects of monitoring glaucoma patients in England.
Boodhna T; Crabb DP
BMC Health Serv Res; 2016 Oct; 16(1):611. PubMed ID: 27770792
[TBL] [Abstract][Full Text] [Related]
17. Cost Effectiveness of Support for People Starting a New Medication for a Long-Term Condition Through Community Pharmacies: An Economic Evaluation of the New Medicine Service (NMS) Compared with Normal Practice.
Elliott RA; Tanajewski L; Gkountouras G; Avery AJ; Barber N; Mehta R; Boyd MJ; Latif A; Chuter A; Waring J
Pharmacoeconomics; 2017 Dec; 35(12):1237-1255. PubMed ID: 28776320
[TBL] [Abstract][Full Text] [Related]
18. Patterns of Glaucoma Medication Adherence over Four Years of Follow-Up.
Newman-Casey PA; Blachley T; Lee PP; Heisler M; Farris KB; Stein JD
Ophthalmology; 2015 Oct; 122(10):2010-21. PubMed ID: 26319441
[TBL] [Abstract][Full Text] [Related]
19. The long-term outcomes of four alternative treatment strategies for primary open-angle glaucoma.
van Gestel A; Webers CA; Severens JL; Beckers HJ; Jansonius NM; Hendrikse F; Schouten JS
Acta Ophthalmol; 2012 Feb; 90(1):20-31. PubMed ID: 22289192
[TBL] [Abstract][Full Text] [Related]
20. Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study.
Kymes SM; Kass MA; Anderson DR; Miller JP; Gordon MO;
Am J Ophthalmol; 2006 Jun; 141(6):997-1008. PubMed ID: 16765666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
